Skip to main content
. 2023 Oct 29;11(11):2924. doi: 10.3390/biomedicines11112924
ABOVE group with a D2B time > 60 min
AFM atomic force microscope
BELOW group with a D2B time ≤ 60 min
BMI body mass index
C3a complement factor C3a
C5a complement factor C5a
cGMP cyclic guanosine monophosphate
CK creatine kinase
CRP c-reactive protein
CVRF cardiovascular risk-factor
D2B door-to-balloon time
ECLS extracorporeal life support
ECMO extracorporeal membrane oxygenation
eGC endothelial glycocalyx
ELISA enzyme-linked immunosorbent assay
ESC European Society of Cardiology
FDC force distance curve
HCl hydrochloric acid
HIGH group with syndecan-1 levels ≤ 120 ng/mL
HUVEC human umbilical vein endothelial cells
I/R ischemia-reperfusion
ICU intensive care unit
IL interleukin
IRI ischemia-reperfusion injury
LDH lactate dehydrogenase
LOW group with syndecan-1 levels ≤ 120 ng/mL
LVEF left ventricular ejection fraction
M mean
MMP matrix metalloproteinases
NO nitric oxide
NOA-280i Nitric Oxide Analyzer-280i
NOx nitric oxide products
PCI percutaneous coronary intervention
Pro-BNP II pro-brain natriuretic peptide II
ROSC return of spontaneous circulation
RR Riva-Rocci, blood pressure
SD standard deviation
STEMI ST-elevation myocardial infarction
Syn-1 syndecan-1
TIMP tissue inhibitor of matrix metalloproteinases
VSMC vascular smooth muscle cells